g. ayhan Et Al. , "P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn," 7th European Congress of Pharmacology , 2016
ayhan, g. Et Al. 2016. P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn. 7th European Congress of Pharmacology .
ayhan, g., duman, n., ÖZKULA, S., aşık, z., GÜLHAN, R., KARAALP, A., ... ONAT, F.(2016). P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn . 7th European Congress of Pharmacology
ayhan, gözde Et Al. "P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn," 7th European Congress of Pharmacology, 2016
ayhan, gözde Et Al. "P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn." 7th European Congress of Pharmacology , 2016
ayhan, g. Et Al. (2016) . "P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn." 7th European Congress of Pharmacology .
@conferencepaper{conferencepaper, author={gözde ayhan Et Al. }, title={P213 Exposure to SSRI and SNRI adtidepressants during pregnancy risk of fetus or newborn}, congress name={7th European Congress of Pharmacology}, city={}, country={}, year={2016}}